No Data
No Data
Neuren Pharmaceuticals Limited (NURPF) Receives a Buy From Canaccord Genuity
Analysts Think These ASX 200 Shares Are Strong Buys
4 ASX Healthcare Stocks Having a Cracking Run on Friday
Those Who Invested in Neuren Pharmaceuticals (ASX:NEU) Three Years Ago Are up 576%
Two Up, One Down: ASX Healthcare Stocks Split After FY24 Results
Neuren Pharmaceuticals Ltd: H1 2024 financial results
No Data
No Data